Topic: Immunocompromised

CNN's John King reveals on-air that he has multiple sclerosis (MS) to explain his personal stake in vaccine mandates. He expresses gratitude for his vaccinated colleagues, citing his status as an immunocompromised individual. The hosts question the clinical link between MS and COVID-19 vulnerability.

Medical experts are urging high-risk groups, including those over 50, pregnant women, and the immunocompromised, to receive updated COVID-19 boosters before holiday gatherings. Officials noted that it takes approximately two weeks for the booster's protection to fully "kick in." The messaging focuses on maintaining "steady" protection as immunity from initial vaccine series wanes over time.

India has reported over 80 cases of "tomato flu" or "tomato fever," primarily affecting children under five in the Kerala region. Health officials believe the virus may be a new variant of hand, foot, and mouth disease, characterized by red blisters, and it is particularly threatening to immunocompromised individuals.

Executive Producer Matt Hyde shared a detailed account of becoming severely ill after being forced to take a Pfizer booster on top of two Moderna doses for work travel. Hyde described symptoms including a constant high temperature, lethargy, and a subsequent heart attack, which his family doctor dismissed as unrelated to the vaccine. This story highlights the frustration of individuals facing medical gaslighting regarding potential adverse reactions.

Commentators argue that the media is overstating the danger of the coronavirus compared to the seasonal flu. They point out that the death rate appears low when considering the likely number of mild, undocumented cases. The discussion emphasizes that the virus primarily poses a risk to the elderly and immunocompromised, while the general public is urged to focus on flu shots.

Former FDA Commissioner and current Pfizer board member Scott Gottlieb appeared on CBS to discuss the potential for annual COVID-19 vaccinations. Gottlieb explained that a fourth dose may be necessary for immunocompromised individuals and that the virus will likely "drift" over time, requiring regular updates. The segment criticizes the media for using Gottlieb as an objective expert while he serves on the board of a vaccine manufacturer.

The FDA and CDC updated guidance to allow a fourth dose of Pfizer or Moderna vaccines for severely immunocompromised individuals, representing roughly 3% of the population. This development follows the rollout of third-dose boosters for 70 million Americans. Critics argue the rapid move to a fourth dose within a year of the initial rollout suggests the vaccines are underperforming.

The FDA advisory committee held an eight-hour meeting resulting in a recommendation against COVID-19 booster shots for the general population, limiting them instead to those 65 and older or the immunocompromised. Dr. Ashish Jha and other experts noted that the initial two doses remain highly effective at preventing hospitalization for young, healthy individuals.

The CDC is now recommending a "third dose" for immunocompromised individuals, specifically distinguishing it from a "booster" shot. This policy change addresses data showing that two doses of the Pfizer or Moderna vaccines were inadequate for certain populations, while the system for tracking multiple doses remains administratively disorganized.

CDC Director Dr. Rochelle Walensky admitted that emerging data suggests COVID-19 vaccines may not work effectively for immunocompromised individuals, such as those undergoing chemotherapy or transplant recipients. She advised these patients to consult their physicians and continue wearing masks despite being fully vaccinated.

A discussion on public health warnings suggests that recently vaccinated individuals may spread diseases to the immunocompromised. Citing a Johns Hopkins patient guide, the hosts note that live vaccines for measles, rubella, and chickenpox can pose a risk to those with weakened immune systems. This "asymptomatic" spread is proposed as a factor in recent outbreaks.